shRNAs targeting HMGN1 were selectively depleted in AML cells compared to all other cancer cell types, suggesting a lineage-specific dependency on HMGN1 in AML (Supplementary Fig. 1b). This evidence concerns the gene HMGN1 and acute myeloid leukemia.